What type of study is this?

This is a Literature Review study.

What question did this study set out to answer?

The aim is to enhance antidepressant therapy for Major Depressive Disorder through innovative approaches.

December 10, 2025Journal of Personalized MedicineOpen Access

Personalizing Antidepressant Therapy: Integrating Pharmacogenomics, Therapeutic Drug Monitoring, and Digital Tools for Improved Depression Outcomes

View Full Paper

Ask AI

Bookmark

Authors

MPMikhail ParshenkovSechenov University SZS. К. ZyryanovPeoples' Friendship University of Russia GRG. М. RodionovaSechenov University

Discussion

Member takes

Implication

Literature review shows improved depression outcomes through pharmacogenetics, AI, and therapeutic drug monitoring, indicating a shift to precision dosing.

Key Points

The aim is to enhance antidepressant therapy for Major Depressive Disorder through innovative approaches.
Literature review of pharmacogenetics testing, therapeutic drug monitoring, and artificial intelligence.
Integration of these fields to improve antidepressant selection.
Analysis of model-informed precision dosing for personalized treatment.
Pharmacological management often relies on trial-and-error, leading to suboptimal outcomes.
Integrating pharmacogenomics and TDM could enhance treatment effectiveness.
Individualized psychiatric care may be achieved through collaborative approaches.

Cite This Study

Parshenkov et al. (2025) studied this question.

synapsesocial.com/papers/69401d412d562116f28f8348 https://doi.org/10.3390/jpm15120616

View Full Paper

Ask AI

Bookmark

Implication

Literature review shows improved depression outcomes through pharmacogenetics, AI, and therapeutic drug monitoring, indicating a shift to precision dosing.

Personalizing Antidepressant Therapy: Integrating Pharmacogenomics, Therapeutic Drug Monitoring, and Digital Tools for Improved Depression Outcomes

Discussion

Member takes

Implication

Key Points

Cite This Study

Personalizing Antidepressant Therapy: Integrating Pharmacogenomics, Therapeutic Drug Monitoring, and Digital Tools for Improved Depression Outcomes

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider